← Search

Data · dataset · 2026

Dataset from a randomized controlled trial of Imipenem/cilastatin/funobactam versus imipenem/cilastatin/relebactam in patients with HABP/VABP.

Listed in ScienceDB

This dataset originates from a first phase 3 clinical study to evaluate the efficacy and safety of a novel β-lactam/β-lactamase inhibitor combination named Imipenem/cilastatin/funobactam in patients with hospital-acquired/ventilator-associated bacterial pneumonia (HABP/VABP).

Links

Where it is published

Catalogue records · 1

Topics

Provenance · 1 source records, 11 field assertions
SourceKeyLast seenRaw
ScienceDB10.57760/sciencedb.2839911 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · scidb cnconnector:scidb_cn@1.0.0
concepts[field].local:field:earth-environmentalmapping · scidb cnconnector:scidb_cn@1.0.0
concepts[field].local:field:engineeringmapping · scidb cnconnector:scidb_cn@1.0.0
concepts[field].local:field:humanitiesmapping · scidb cnconnector:scidb_cn@1.0.0
concepts[field].local:field:life-sciencesmapping · scidb cnconnector:scidb_cn@1.0.0
concepts[field].local:field:medicine-healthmapping · scidb cnconnector:scidb_cn@1.0.0
concepts[field].local:field:social-sciencemapping · scidb cnconnector:scidb_cn@1.0.0
descriptionsource · scidb cnconnector:scidb_cn@1.0.0/metadata/dc/description
license_textsource · scidb cnconnector:scidb_cn@1.0.0
publication_datesource · scidb cnconnector:scidb_cn@1.0.0
titlesource · scidb cnconnector:scidb_cn@1.0.0/metadata/dc/title